Adrenergic receptor 3D structures
From Proteopedia
(Difference between revisions)
(New page: == 3D Structures of Adrenergic receptor == Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *α-2 adrenergic recepto...) |
|||
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | == 3D Structures of Adrenergic receptor == | + | == 3D Structures of [[Adrenergic receptor]] == |
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| + | |||
| + | *α-1B adrenergic receptor | ||
| + | |||
| + | **[[7b6w]] – hA1AR + agonist<br /> | ||
*α-2 adrenergic receptor | *α-2 adrenergic receptor | ||
| - | **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – | + | **[[6kuy]] – hA2AR + partial agonist<br /> |
| - | **[[1hof]], [[1hll]] - hA2AR peptide – NMR<br /> | + | **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – NMR |
| + | **[[1hof]], [[1hll]] - hA2AR peptide – NMR | ||
| + | **[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br /> | ||
| + | **[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br /> | ||
| + | **[[7ej0]], [[7ej8]], [[7eja]], [[7ejk]] – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM<br /> | ||
| + | **[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br /> | ||
*β-1 adrenergic receptor | *β-1 adrenergic receptor | ||
| + | **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine - human<br /> | ||
| + | **[[7bu6]], [[7bu7]] – hB1AR/endolysin + nanobody + epinephrine derivative<br /> | ||
| + | **[[7bvq]] – hB1AR/endolysin + carazolol<br /> | ||
**[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | **[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | ||
**[[1dep]] – tB1AR peptide - NMR<br /> | **[[1dep]] – tB1AR peptide - NMR<br /> | ||
| Line 17: | Line 29: | ||
**[[3zpq]], [[3zpr]] - tB1AR fragment (mutant) + aryl piperazine inhibitor<br /> | **[[3zpq]], [[3zpr]] - tB1AR fragment (mutant) + aryl piperazine inhibitor<br /> | ||
**[[4bvn]] - tB1AR + cyanopindolol<br /> | **[[4bvn]] - tB1AR + cyanopindolol<br /> | ||
| - | **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]] – tB1AR (mutant) + | + | **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]], [[6ibl]] – tB1AR (mutant) + nanobody + thioredoxin + agonist<br /> |
| + | **[[7s0f]], [[7s0g]] - tB1AR + guanine nucleotide-binding protein + drug – Cryo EM<br /> | ||
| + | **[[7jjo]] - tB1AR + guanine nucleotide-binding protein + nanobody + drug – Cryo EM<br /> | ||
| + | **[[6tko]] - tB1AR + arrestin + antibody + modulator – Cryo EM<br /> | ||
*β-2 adrenergic receptor | *β-2 adrenergic receptor | ||
| + | **[[6kr8]] - hB2AR<br /> | ||
**[[3pds]] - hB2AR/T4 lysozyme<br /> | **[[3pds]] - hB2AR/T4 lysozyme<br /> | ||
| - | **[[3p0g]] – hB2AR/T4 lysozyme + | + | **[[3p0g]] – hB2AR/T4 lysozyme + nanobody<br /> |
| - | **[[4lde]], [[4ldl]], [[4ldo]] - hB2AR/T4 lysozyme (mutant) + | + | **[[4lde]], [[4ldl]], [[4ldo]] - hB2AR/T4 lysozyme (mutant) + nanobody<br /> |
**[[2r4s]],[[2r4r]] - hB2AR + Fab5 complex<br /> | **[[2r4s]],[[2r4r]] - hB2AR + Fab5 complex<br /> | ||
**[[2rh1]] - hB2AR/T4 lysozyme (mutant)<br /> | **[[2rh1]] - hB2AR/T4 lysozyme (mutant)<br /> | ||
| Line 30: | Line 46: | ||
**[[6mxt]] - hB2AR/T4 lysozyme (mutant) + antibody + salmeterol<br /> | **[[6mxt]] - hB2AR/T4 lysozyme (mutant) + antibody + salmeterol<br /> | ||
**[[5x7d]] - hB2AR/T4 lysozyme (mutant) + carazolol + inhibitor<br /> | **[[5x7d]] - hB2AR/T4 lysozyme (mutant) + carazolol + inhibitor<br /> | ||
| + | **[[6oba]] - hB2AR/T4 lysozyme (mutant) + modulator<br /> | ||
| + | **[[6ps0]], [[6prz]], [[6ps2]], [[6ps3]], [[6ps4]], [[6ps5]], [[6ps6]] - hB2AR + cholesterol + carazolol derivative<br /> | ||
| + | **[[6ps1]] - hB2AR + cholesterol + timolol<br /> | ||
**[[5d5a]], [[5d5b]] - hB2AR (mutant) + cholesterol + carazolol<br /> | **[[5d5a]], [[5d5b]] - hB2AR (mutant) + cholesterol + carazolol<br /> | ||
**[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | **[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | ||
**[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | **[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | ||
| - | **[[3sn6]] - human β-2 adrenergic receptor + | + | **[[6n48]] - hB2AR/endolysin + nanobody + modulator<br /> |
| + | **[[3sn6]] - human β-2 adrenergic receptor + nano body bound by guanine nucleotide-binding protein G<br /> | ||
| + | **[[7bz2]], [[7dhi]], [[7dhr]] – hB2AR + guanine nucleotide-binding protein + nanobody + modulator – Cryo EM<br /> | ||
**[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | **[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | ||
**[[4qkx]] – B2AR + R9 protein - llama<br /> | **[[4qkx]] – B2AR + R9 protein - llama<br /> | ||
| + | |||
| + | *β-3 adrenergic receptor | ||
| + | |||
| + | **[[7dh5]], [[7xjh]], a[[7xji]] – B3AR + guanine nucleotide-binding protein + nanobody + drug – dog - Cryo EM<br /> | ||
| + | |||
}} | }} | ||
| + | [[Category: Topic Page]] | ||
Current revision
3D Structures of Adrenergic receptor
Updated on 12-December-2022
